胆酸GMP

概述

Chenodeoxycholic Acid (CDCA) is a primary bile acid with critical applications in the pharmaceutical industry. It plays a key role in bile acid metabolism and is widely used in drug formulations for treating gallstones and metabolic disorders. Our GMP-certified CDCA ensures the highest standards of purity and compliance for pharmaceutical use.

Manufacturing Process & Quality Assurance

Our Chenodeoxycholic Acid is derived from high-quality raw materials using a strictly controlled manufacturing process. The production follows Good Manufacturing Practices (GMP), ensuring safety, consistency, and compliance with international pharmaceutical standards. Our facility maintains rigorous quality assurance protocols, including BSE/TSE-free certification and full regulatory documentation, such as Drug Master Files (DMF) and Certificates of Suitability (CEPs).

应用

• Gallstone Dissolution: CDCA is used as an active pharmaceutical ingredient (API) in non-surgical treatment of cholesterol gallstones.
• Cerebrotendinous Xanthomatosis (CTX): CDCA therapy reduces cholestanol levels, helping manage neurological symptoms in this rare metabolic disorder.
• Metabolic Disorders: Plays a role in regulating cholesterol metabolism and bile acid synthesis.

最终用途

Chenodeoxycholic Acid is used as an active pharmaceutical ingredient (API) in certain drug formulations for gallstone dissolution and for the treatment of rare metabolic disorders. It is also used as a key intermediate for the production of other bioactive pharmaceuticals. It can be used as an excipient in drug formulations to enhance the solubility and stability of poorly water-soluble drugs, peptides, and proteins, while facilitating their permeation across biological membranes.

研究与开发

Ongoing studies are exploring new applications of CDCA, including its potential role in neuroprotection for diseases such as Alzheimer’s and Parkinson’s. Emerging research also suggests applications in lipid metabolism regulation.

Packaging & Availability

Our GMP-certified Chenodeoxycholic Acid is available in secure packaging options to meet pharmaceutical industry requirements. Standard packaging sizes include 50kg containers, with customized solutions available upon request.